Safety Evaluation of COVID-19 Vaccine in Patients With IgA Nephropathy or IgA Vasculitis Nephritis

Jincan Zan; Jun Ma; Qian Man; Xingzi Liu; Donghe Yu; Yuemiao Zhang; Jicheng Lv; Hong Zhang

doi:10.1016/j.ekir.2022.03.025

Safety Evaluation of COVID-19 Vaccine in Patients With IgA Nephropathy or IgA Vasculitis Nephritis

Kidney Int Rep. 2022 Jun;7(6):1435-1436. doi: 10.1016/j.ekir.2022.03.025. Epub 2022 Apr 4.

Authors

Jincan Zan^{1

2

3

4}, Jun Ma^{1

2

3

4}, Qian Man^{1

2

3

4}, Xingzi Liu^{1

2

3

4}, Donghe Yu^{1

2

3

4}, Yuemiao Zhang^{1

2

3

4}, Jicheng Lv^{1

2

3

4}, Hong Zhang^{1

2

3

4}

Affiliations

¹ Renal Division, Peking University First Hospital, Beijing, China.
² Peking University Institute of Nephrology, Peking University Health Science Center, Beijing, China.
³ Key Laboratory of Kidney Disease, Ministry of Health of China, Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Beijing, China.
⁴ Research Units of Diagnosis and Treatment of Immune-mediate Kidney Disease, Chinese Academy of Medical Sciences, Beijing, China.

No abstract available